<bill session="108" type="h" number="1400" updated="2013-07-14T19:01:08-04:00">
  <state datetime="2003-03-20">REFERRED</state>
  <status>
    <introduced datetime="2003-03-20"/>
  </status>
  <introduced datetime="2003-03-20"/>
  <titles>
    <title as="introduced" type="short">Prescription Drug Fairness for Seniors Act of 2003</title>
    <title as="introduced" type="official">To provide for substantial reductions in the price of prescription drugs for Medicare beneficiaries.</title>
  </titles>
  <sponsor id="400007"/>
  <cosponsors>
    <cosponsor id="400011" joined="2003-04-03"/>
    <cosponsor id="400013" joined="2003-06-05"/>
    <cosponsor id="400026" joined="2003-03-20"/>
    <cosponsor id="400033" joined="2003-06-26"/>
    <cosponsor id="400044" joined="2003-04-03"/>
    <cosponsor id="400048" joined="2003-03-20"/>
    <cosponsor id="400050" joined="2003-03-20"/>
    <cosponsor id="400069" joined="2003-03-20"/>
    <cosponsor id="400074" joined="2003-05-15"/>
    <cosponsor id="400080" joined="2003-03-20"/>
    <cosponsor id="400087" joined="2003-04-03"/>
    <cosponsor id="400090" joined="2004-09-17"/>
    <cosponsor id="400103" joined="2003-04-03"/>
    <cosponsor id="400111" joined="2003-04-11"/>
    <cosponsor id="400143" joined="2003-03-20"/>
    <cosponsor id="400160" joined="2003-03-20"/>
    <cosponsor id="400178" joined="2003-03-20"/>
    <cosponsor id="400215" joined="2003-03-20"/>
    <cosponsor id="400223" joined="2003-03-20"/>
    <cosponsor id="400227" joined="2003-03-20"/>
    <cosponsor id="400230" joined="2003-05-15"/>
    <cosponsor id="400233" joined="2004-02-03"/>
    <cosponsor id="400249" joined="2003-06-23"/>
    <cosponsor id="400251" joined="2003-03-20"/>
    <cosponsor id="400257" joined="2003-03-20"/>
    <cosponsor id="400259" joined="2003-05-15"/>
    <cosponsor id="400262" joined="2003-04-03"/>
    <cosponsor id="400268" joined="2003-03-20"/>
    <cosponsor id="400269" joined="2003-04-03"/>
    <cosponsor id="400274" joined="2003-03-20"/>
    <cosponsor id="400286" joined="2003-04-03"/>
    <cosponsor id="400289" joined="2003-03-20"/>
    <cosponsor id="400295" joined="2003-03-20"/>
    <cosponsor id="400299" joined="2003-03-20"/>
    <cosponsor id="400300" joined="2003-05-15"/>
    <cosponsor id="400301" joined="2003-05-15"/>
    <cosponsor id="400306" joined="2003-06-05"/>
    <cosponsor id="400308" joined="2003-03-20"/>
    <cosponsor id="400310" joined="2003-03-20"/>
    <cosponsor id="400312" joined="2003-04-03"/>
    <cosponsor id="400345" joined="2003-06-05"/>
    <cosponsor id="400347" joined="2003-03-20"/>
    <cosponsor id="400354" joined="2003-03-20"/>
    <cosponsor id="400356" joined="2003-04-03"/>
    <cosponsor id="400357" joined="2003-04-03"/>
    <cosponsor id="400358" joined="2003-04-03"/>
    <cosponsor id="400360" joined="2003-03-20"/>
    <cosponsor id="400366" joined="2003-03-20"/>
    <cosponsor id="400378" joined="2003-06-05"/>
    <cosponsor id="400387" joined="2003-03-20"/>
    <cosponsor id="400390" joined="2003-05-15"/>
    <cosponsor id="400391" joined="2003-04-03"/>
    <cosponsor id="400407" joined="2003-06-05"/>
    <cosponsor id="400422" joined="2003-06-05"/>
    <cosponsor id="400425" joined="2003-03-20"/>
    <cosponsor id="400426" joined="2003-05-15"/>
    <cosponsor id="400430" joined="2003-03-20"/>
    <cosponsor id="400436" joined="2003-03-20"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2003-03-20">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-03-20">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2003-03-20">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2003-03-26">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Ways and Means"/>
    </action>
    <action datetime="2003-04-10">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Energy and Commerce"/>
    </action>
    <action datetime="2003-06-02">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR H4765-4766"/>
    </action>
    <action datetime="2003-06-23">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR H5698-5699"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSWM02" subcommittee="Health" name="House Ways and Means"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Ambulatory care"/>
    <term name="Canada"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="East Asia"/>
    <term name="Europe"/>
    <term name="Foreign trade and international finance"/>
    <term name="France"/>
    <term name="Germany"/>
    <term name="Government contractors"/>
    <term name="Government operations and politics"/>
    <term name="Italy"/>
    <term name="Japan"/>
    <term name="Medicare"/>
    <term name="Pharmacies"/>
    <term name="Prescription pricing"/>
    <term name="Price discrimination"/>
    <term name="Social welfare"/>
    <term name="Terminal care"/>
    <term name="Terminally ill"/>
    <term name="United Kingdom"/>
  </subjects>
  <amendments/>
  <summary>3/20/2003--Introduced.
Prescription Drug Fairness for Seniors Act of 2003 - Requires each participating manufacturer of a covered outpatient drug to make it available for purchase by each pharmacy: (1) in an amount equal to the aggregate amount sold or distributed by the pharmacy to Medicare beneficiaries; and (2) at a price no greater than the manufacturer's average foreign price. Sets forth special provisions with respect to hospice programs.</summary>
</bill>
